INMD vs VCYT: fair value comparison
InMode Ltd. and Veracyte, Inc. · Updated 2026-10-19
Both currently screen as fairly valued on TickrTrends' Forward Fair Value model. Within Healthcare, VCYT currently sits closer to the top of our ranking by discount to fair value.
| INMD | VCYT | |
|---|---|---|
| Verdict | Fairly valued | Fairly valued |
| Last price | $14.16 | $43.12 |
| 12-month range | $12.76–$16.62 | $30.01–$60.49 |
| Rank by discount to fair value | #66 of 108 Healthcare | #65 of 108 Healthcare |
| Quality grade | A | A |
| Leverage | Low | Low |
| Margin trend | Contracting | Expanding |
| Revenue growth | Declining | Strong |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Mixed | Mixed |
| DCF cross-check | Overvalued | — |
| 52-week position | The lower-middle quarter | The lower-middle quarter |
Full single-stock breakdowns: INMD fair value analysis · VCYT fair value analysis